Neoantigenics, Pfizer partnership invests in cancer drugs
By Samantha Josey-Borden | January 30, 2014Neoantigenics LLC, an oncology biotechnology company established in 2012 and grown out of University research partners, has secured patents on technology to better target and eliminate certain types of cancer using natural human proteins.